Similar articles for PMID: 30098338

Year	Number of Results
2014	1
2015	5
2016	5
2017	15
2018	25
2019	26
2020	19
2021	12
2022	5
2023	2
2024	0

1

Temporal and Spatial Epigenome Editing Allows Precise Gene Regulation in Mammalian Cells.

Kuscu C, Mammadov R, Czikora A, Unlu H, Tufan T, Fischer NL, Arslan S, Bekiranov S, Kanemaki M, Adli M. Kuscu C, et al. J Mol Biol. 2019 Jan 4;431(1):111-121. doi: 10.1016/j.jmb.2018.08.001. Epub 2018 Aug 9. J Mol Biol. 2019. PMID: 30098338

2

Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements.

Thakore PI, D'Ippolito AM, Song L, Safi A, Shivakumar NK, Kabadi AM, Reddy TE, Crawford GE, Gersbach CA. Thakore PI, et al. Nat Methods. 2015 Dec;12(12):1143-9. doi: 10.1038/nmeth.3630. Epub 2015 Oct 26. Nat Methods. 2015. PMID: 26501517 Free PMC article.

3

Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.

Okada M, Kanamori M, Someya K, Nakatsukasa H, Yoshimura A. Okada M, et al. Epigenetics Chromatin. 2017 May 8;10:24. doi: 10.1186/s13072-017-0129-1. eCollection 2017. Epigenetics Chromatin. 2017. PMID: 28503202 Free PMC article.

4

Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.

Kabadi AM, Machlin L, Dalal N, Lee RE, McDowell I, Shah NN, Drowley L, Randell SH, Reddy TE. Kabadi AM, et al. J Cyst Fibros. 2022 Jan;21(1):164-171. doi: 10.1016/j.jcf.2021.04.008. Epub 2021 May 25. J Cyst Fibros. 2022. PMID: 34049825 Free PMC article.

5

Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.

Hilton IB, D'Ippolito AM, Vockley CM, Thakore PI, Crawford GE, Reddy TE, Gersbach CA. Hilton IB, et al. Nat Biotechnol. 2015 May;33(5):510-7. doi: 10.1038/nbt.3199. Epub 2015 Apr 6. Nat Biotechnol. 2015. PMID: 25849900 Free PMC article.

6

Keeping our eyes on CRISPR: the "Atlas" of gene editing.

Wang W, Hou J, Zheng N, Wang X, Zhang J. Wang W, et al. Cell Biol Toxicol. 2019 Aug;35(4):285-288. doi: 10.1007/s10565-019-09480-w. Epub 2019 Jun 5. Cell Biol Toxicol. 2019. PMID: 31165372 No abstract available.

7

CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome.

Klann TS, Black JB, Chellappan M, Safi A, Song L, Hilton IB, Crawford GE, Reddy TE, Gersbach CA. Klann TS, et al. Nat Biotechnol. 2017 Jun;35(6):561-568. doi: 10.1038/nbt.3853. Epub 2017 Apr 3. Nat Biotechnol. 2017. PMID: 28369033 Free PMC article.

8

CRISPR as a strong gene editing tool.

Shen S, Loh TJ, Shen H, Zheng X, Shen H. Shen S, et al. BMB Rep. 2017 Jan;50(1):20-24. doi: 10.5483/bmbrep.2017.50.1.128. BMB Rep. 2017. PMID: 27616359 Free PMC article. Review.

9

Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing.

Li K, Liu Y, Cao H, Zhang Y, Gu Z, Liu X, Yu A, Kaphle P, Dickerson KE, Ni M, Xu J. Li K, et al. Nat Commun. 2020 Jan 24;11(1):485. doi: 10.1038/s41467-020-14362-5. Nat Commun. 2020. PMID: 31980609 Free PMC article.

10

Battling CRISPR-Cas9 off-target genome editing.

Li D, Zhou H, Zeng X. Li D, et al. Cell Biol Toxicol. 2019 Oct;35(5):403-406. doi: 10.1007/s10565-019-09485-5. Epub 2019 Jul 16. Cell Biol Toxicol. 2019. PMID: 31313008 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year